Suppr超能文献

糖原贮积病患者的肝细胞癌和肝脏局灶性结节性增生

Hepatocellular carcinoma and focal nodular hyperplasia of the liver in a glycogen storage disease patient.

作者信息

Mikuriya Yoshihiro, Oshita Akihiko, Tashiro Hirotaka, Amano Hironobu, Kobayashi Tsuyoshi, Arihiro Kouji, Ohdan Hideki

机构信息

Yoshihiro Mikuriya, Akihiko Oshita, Hirotaka Tashiro, Hironobu Amano, Tsuyoshi Kobayashi, Hideki Ohdan, Division of Frontier Medical Science, Department of Surgery, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8551, Japan.

出版信息

World J Hepatol. 2012 Jun 27;4(6):191-5. doi: 10.4254/wjh.v4.i6.191.

Abstract

Glycogen storage disease type Ia (GSD-Ia; also called von Gierke disease) is an autosomal recessive disorder of carbohydrate metabolism caused by glucose-6-phosphatase deficiency. There have been many reports describing hepatic tumors in GSD patients; however, most of these reports were of hepatocellular adenomas, whereas there are only few reports describing focal nodular hyperplasia (FNH) or hepatocellular carcinoma (HCC). We report a case with GSD-Ia who had undergone a partial resection of the liver for FNH at 18 years of age and in whom moderately differentiated HCC had developed. Preoperative imaging studies, including ultrasonography, dynamic computer tomography (CT) and magnetic resonance imaging, revealed benign and malignant features. In particular, fluorodeoxyglucose-positron emission tomography (FDG-PET)/CT revealed the atypical findings that FDG accumulated at high levels in the non-tumorous hepatic parenchyma and low levels in the tumor. Right hemihepatectomy was performed. During the perioperative period, high-dose glucose and sodium bicarbonate were administered to control metabolic acidosis. He had multiple recurrences of HCC at 10 mo after surgery and was followed-up with transcatheter arterial chemoembolization. The tumor was already highly advanced when it was found by chance; therefore, a careful follow-up should be mandatory for GSD-I patients as they are at a high risk for HCC, similar to hepatitis patients.

摘要

Ia型糖原贮积病(GSD-Ia;也称为冯·吉尔克病)是一种由葡萄糖-6-磷酸酶缺乏引起的常染色体隐性碳水化合物代谢紊乱疾病。已有许多关于GSD患者肝脏肿瘤的报道;然而,这些报道大多是关于肝细胞腺瘤的,而描述局灶性结节性增生(FNH)或肝细胞癌(HCC)的报道很少。我们报告一例GSD-Ia患者,该患者18岁时因FNH接受了部分肝切除术,术后发生了中度分化的HCC。术前影像学检查,包括超声、动态计算机断层扫描(CT)和磁共振成像,显示出良性和恶性特征。特别是,氟脱氧葡萄糖-正电子发射断层扫描(FDG-PET)/CT显示了非典型表现,即FDG在非肿瘤性肝实质中高水平积聚,而在肿瘤中低水平积聚。进行了右半肝切除术。围手术期给予高剂量葡萄糖和碳酸氢钠以控制代谢性酸中毒。术后10个月,他的HCC多次复发,并接受了经动脉化疗栓塞治疗。偶然发现肿瘤时已经处于晚期;因此,对于GSD-I患者,应像肝炎患者一样,强制进行仔细的随访,因为他们患HCC的风险很高。

相似文献

3
Type La glycogen storage disease with focal nodular hyperplasia in siblings.
Acta Paediatr Jpn. 1995 Aug;37(4):510-3. doi: 10.1111/j.1442-200x.1995.tb03365.x.
10
Activation of glycolysis and apoptosis in glycogen storage disease type Ia.Ia型糖原贮积病中糖酵解和细胞凋亡的激活
Mol Genet Metab. 2009 Aug;97(4):267-71. doi: 10.1016/j.ymgme.2009.04.003. Epub 2009 Apr 10.

引用本文的文献

4
Glycogen storage disease type 1a in the Ohio Amish.俄亥俄阿米什人中的1a型糖原贮积病。
JIMD Rep. 2022 Jun 21;63(5):453-461. doi: 10.1002/jmd2.12310. eCollection 2022 Sep.

本文引用的文献

1
Liver transplantation for glycogen storage disease type Ia.肝移植治疗糖原贮积症 Ia 型。
J Hepatol. 2009 Sep;51(3):483-90. doi: 10.1016/j.jhep.2009.05.026. Epub 2009 Jun 17.
7
Glycogen storage disease I and hepatocellular tumours.糖原贮积病I型与肝细胞肿瘤
Eur J Pediatr. 1993;152 Suppl 1:S63-70. doi: 10.1007/BF02072092.
8
Glycogen storage disease in adults.成人糖原贮积病
Ann Intern Med. 1994 Feb 1;120(3):218-26. doi: 10.7326/0003-4819-120-3-199402010-00008.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验